Kevin Sabet

Kevin Sabet is an American policy analyst, academic, and commentator known for his work on drug policy, public health, and cannabis regulation. He has held positions in federal administrations, founded advocacy organizations, and authored books and articles on substance use policy. Sabet engages regularly with media outlets, legislative bodies, and international organizations concerning drug regulation, prevention, and treatment.

Early life and education

Sabet studied at Yale University where he earned undergraduate credentials and engaged with campus policy discussions alongside contemporaries from institutions such as Harvard University and Princeton University. He pursued postgraduate study at the University of Cambridge and obtained advanced degrees from the University of Oxford and the University of Kentucky, interacting with scholars affiliated with King's College London, Columbia University, Johns Hopkins University, and University College London. During his academic formation he worked with researchers connected to National Institutes of Health, World Health Organization, Centers for Disease Control and Prevention, and policy centers like the Brookings Institution and the RAND Corporation.

Career

Sabet served in advisory roles within the administrations of Bill Clinton and Barack Obama, contributing to initiatives at agencies including the Office of National Drug Control Policy and collaborating with officials linked to Department of Health and Human Services and the Department of Justice. He founded and led organizations focused on drug policy, engaging with coalitions that included entities such as Partnership to End Addiction, Drug Enforcement Administration, Substance Abuse and Mental Health Services Administration, and international partners like the European Monitoring Centre for Drugs and Drug Addiction and the United Nations Office on Drugs and Crime. Sabet has held academic appointments associated with University of Florida, University of Minnesota, University of Pennsylvania, and think tanks including the Cato Institute and the American Enterprise Institute as a visiting scholar or lecturer. He has testified before legislative bodies such as the United States Congress, state legislatures in California, Colorado, and New York, and international assemblies like the Organization of American States.

Views and advocacy

Sabet advocates for regulatory approaches to substances, favoring frameworks informed by public health institutions such as the World Health Organization and research produced at National Institutes of Health laboratories and universities like Yale School of Medicine and Johns Hopkins Bloomberg School of Public Health. He argues against full commercialization models adopted in states like Colorado, Washington (state), and Oregon, proposing instead regulated systems modeled on frameworks used for alcohol and tobacco in jurisdictions such as Canada and Portugal. His positions have overlapped with advocacy groups including Smart Approaches to Marijuana, coalitions tied to Americans for Responsible Solutions, and coalitions that have lobbied in states including New Jersey, Massachusetts, and Michigan. Sabet supports prevention and treatment investments aligned with programs developed by SAMHSA and models promoted by European Monitoring Centre for Drugs and Drug Addiction and academic centers at Rutgers University and Duke University.

Publications and media appearances

Sabet is the author and coauthor of books and numerous articles appearing in outlets such as The New York Times, The Washington Post, The Wall Street Journal, National Review, and The Atlantic. His academic publications have been published alongside scholars from Harvard Medical School, Columbia University, Yale School of Public Health, and University of California, Los Angeles in journals read by experts at American Journal of Public Health and policy reviews connected to Brookings Institution and RAND Corporation. He has appeared on broadcast platforms including CNN, Fox News, MSNBC, PBS NewsHour, and BBC News, participating in panels with commentators from The New Yorker, Politico, The Guardian, and Time (magazine). Sabet has presented at conferences organized by National Academy of Medicine, American Public Health Association, International Society for Addiction Medicine, and at universities such as Stanford University and Georgetown University.

Controversies and criticism

Sabet's advocacy has generated criticism from figures and organizations that include academics at University of California, Berkeley, advocates from Marijuana Policy Project, policy analysts at Drug Policy Alliance, and commentators linked to The New Republic and Mother Jones. Critics have argued that his connections with advocacy groups and certain funding sources resemble networked campaigns observed in debates involving tobacco industry strategies and controversies surrounding researchers affiliated with pharmaceutical companies and think tanks like the Heritage Foundation. Opponents have cited differing interpretations of data from institutions such as National Highway Traffic Safety Administration and studies from JAMA Psychiatry and Lancet Psychiatry in disagreements over impacts on traffic safety, adolescent use, and public health outcomes in jurisdictions including Alaska and Washington, D.C.. Sabet has responded in op-eds and testimony, engaging with scholars from Harvard University, legal analysts connected to American Civil Liberties Union, and policy experts at Pew Research Center to defend his proposals.

Category:Living people Category:American policy analysts Category:Drug policy